Ge, P., Cao, L., Chen, X., Jing, R., & Yue, W. (2019). miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer. BMC Cancer.
Styl ChicagoGe, Peng, Lei Cao, Xin Chen, Ruijun Jing, a Wanxia Yue. "MiR-762 Activation Confers Acquired Resistance to Gefitinib in Non-small Cell Lung Cancer." BMC Cancer 2019.
Citace podle MLAGe, Peng, et al. "MiR-762 Activation Confers Acquired Resistance to Gefitinib in Non-small Cell Lung Cancer." BMC Cancer 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..